🔴 Neuronetics is trading 7.7% down in pre-market with no clear company-specific catalyst identified

Neuronetics is trading at $1.80, down 7.7%, with no clear company-specific announcement identified to explain its October 16 pre-market decline.

• Shares closed October 15 at $1.95.
• Recent coverage refers to earlier company developments, not a new catalyst for this move.
• Healthcare was higher pre-market while major indices were mixed; these signals do not clearly explain the decline. No pre-market volume figure was provided.